Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Sep 18;24(1):561.
doi: 10.1186/s13054-020-03260-3.

Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study

Akshay Shah  1   2 , Killian Donovan  3 , Anna McHugh  4 , Manish Pandey  5 , Louise Aaron  3 , Charlotte A Bradbury  6 , Simon J Stanworth  7   8 , Raza Alikhan  9 , Stephen Von Kier  10 , Keith Maher  10 , Nicola Curry  8   11 , Susan Shapiro  8   11 , Matthew J Rowland  3   12 , Matt Thomas  4 , Richard Mason  4 , Matthew Holland  4 , Tom Holmes  5 , Michael Ware  5 , Stefan Gurney  13 , Stuart R McKechnie  3
Affiliations
Observational Study

Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study

Akshay Shah et al. Crit Care. .

Abstract

Background: Optimal prophylactic and therapeutic management of thromboembolic disease in patients with COVID-19 remains a major challenge for clinicians. The aim of this study was to define the incidence of thrombotic and haemorrhagic complications in critically ill patients with COVID-19. In addition, we sought to characterise coagulation profiles using thromboelastography and explore possible biological differences between patients with and without thrombotic complications.

Methods: We conducted a multicentre retrospective observational study evaluating all the COVID-19 patients received in four intensive care units (ICUs) of four tertiary hospitals in the UK between March 15, 2020, and May 05, 2020. Clinical characteristics, laboratory data, thromboelastography profiles and clinical outcome data were evaluated between patients with and without thrombotic complications.

Results: A total of 187 patients were included. Their median (interquartile (IQR)) age was 57 (49-64) years and 124 (66.3%) patients were male. Eighty-one (43.3%) patients experienced one or more clinically relevant thrombotic complications, which were mainly pulmonary emboli (n = 42 (22.5%)). Arterial embolic complications were reported in 25 (13.3%) patients. ICU length of stay was longer in patients with thrombotic complications when compared with those without. Fifteen (8.0%) patients experienced haemorrhagic complications, of which nine (4.8%) were classified as major bleeding. Thromboelastography demonstrated a hypercoagulable profile in patients tested but lacked discriminatory value between those with and without thrombotic complications. Patients who experienced thrombotic complications had higher D-dimer, ferritin, troponin and white cell count levels at ICU admission compared with those that did not.

Conclusion: Critically ill patients with COVID-19 experience high rates of venous and arterial thrombotic complications. The rates of bleeding may be higher than previously reported and re-iterate the need for randomised trials to better understand the risk-benefit ratio of different anticoagulation strategies.

Keywords: COVID-19; Haemorrhage; Heparin; Thrombosis.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Description of thrombotic and haemorrhagic complications
See this image and copyright information in PMC

References

    1. Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. 2020. 10.1007/s00134-020-06088-1. - PMC - PubMed
    1. Mojoli F, Mongodi S, Orlando A, Arisi E, Pozzi M, Civardi L, et al. Our recommendations for acute management of COVID-19. Crit Care. 2020;24:207. doi: 10.1186/s13054-020-02930-6. - DOI - PMC - PubMed
    1. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA. 2020;323:1499–1500. doi: 10.1001/jama.2020.3633. - DOI - PubMed
    1. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020. 10.1056/NEJMoa2015432. - PMC - PubMed
    1. Wang Y, Lu X, Chen H, Chen T, Su N, Huang F, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201:1430–1434. doi: 10.1164/rccm.202003-0736LE. - DOI - PMC - PubMed

Publication types

MeSH terms